UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 161 filers reported holding UNIQURE NV in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,208,000 | -1.5% | 64,788 | -4.6% | 0.06% | 0.0% |
| Q1 2022 | $1,227,000 | +22.8% | 67,905 | +41.0% | 0.06% | +4.9% |
| Q4 2021 | $999,000 | +30.2% | 48,171 | +101.1% | 0.06% | +41.9% |
| Q3 2021 | $767,000 | +95.2% | 23,954 | +87.6% | 0.04% | +104.8% |
| Q2 2021 | $393,000 | -36.4% | 12,768 | -30.4% | 0.02% | -40.0% |
| Q1 2021 | $618,000 | +42.1% | 18,340 | +52.2% | 0.04% | +12.9% |
| Q4 2020 | $435,000 | -55.8% | 12,050 | -55.0% | 0.03% | -3.1% |
| Q3 2020 | $985,000 | -54.2% | 26,753 | -10.9% | 0.03% | +6.7% |
| Q4 2019 | $2,152,000 | +860.7% | 30,025 | +428.3% | 0.03% | +900.0% |
| Q3 2019 | $224,000 | – | 5,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |